Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection

NCT03487848 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Hepatitis C
Chronic Hepatitis

Interventions

DRUG: Daclatasvir
DRUG: Sofosbuvir

Sponsor

Bristol-Myers Squibb